Richard T Proffitt

Title: Richard T. Proffitt: Innovator in Antibiotic Formulation

Introduction

Richard T. Proffitt is an accomplished inventor based in the United States. He has made significant contributions to the field of antibiotic formulations, particularly focusing on the treatment of bacterial infections. His innovative work has the potential to impact the medical community positively.

Latest Patents

Richard T. Proffitt holds a patent for an antibiotic formulation and its use for bacterial infections. This patent describes a liposomal aminoglycoside formulation that comprises a neutrallipid, a negatively charged lipid, and a sterol. The formulation contains unilamellar vesicles with an average size below 100 nm. Additionally, the patent outlines a process for making liposomes containing an aminoglycoside and a method for treating both drug-susceptible and drug-resistant bacteria.

Career Highlights

Richard T. Proffitt is associated with Amplimed, Inc., where he continues to work on innovative solutions in the field of antibiotics. His expertise and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Richard has collaborated with notable colleagues, including Evan M. Hersch and Eskild A. Petersen. These partnerships have fostered a collaborative environment that encourages innovation and the development of new therapeutic approaches.

Conclusion

Richard T. Proffitt's work in antibiotic formulation showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against bacterial infections, particularly in addressing the challenges posed by drug-resistant strains.